跳至主要内容
临床试验/NCT04619160
NCT04619160Unknown4 期

Influence of Propofol Versus Sevoflurane on Surgical Conditions During Functional Endoscopic Sinus Surgery

Algemeen Ziekenhuis Maria Middelares1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年3月1日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
发起方
入组人数
60
试验地点
1
主要终点
Boezaart surgical grading scale

研究概览

简要总结

Good surgical conditions are crucial for an optimal surgery result and safe procedure. Minimal blood loss in the surgical field is one of the most important conditions to maintain a good visualization, especially in surgeries with a small surgical field such as a FESS (functional endoscopic sinus surgery). The perioperative blood loss is determined by the main arterial and venous pressure, the local pressure and the capillary vascular filling pressure.

It has been proposed that propofol is a venodilator, which increases the blood flow, but decreases the capillary pressure. On the contrary, sevoflurane might act mainly on the arterioles, which causes an increase in the capillary pressure. In a previous study it has been demonstrated that despite blood pressure maintenance, propofol causes less bleeding during spinal surgery than sevoflurane.

The main aim of this study was to compare both anaesthetics on the perioperative bleeding and haemodynamics during FESS. Secondary, the postoperative nausea, vomiting, pain scores, surgery duration and length of stay at the post-anesthesia care unit will be evaluated.

详细描述

2 X 30 patients which are planned for FESS surgery are randomized in a sevoflurane group or propofol group.

All patients will be induced with propofol (target-controlled infusion (TCI) 4 µg/mL) and remifentanil (TCI 4 ng/mL) and receive a multimodal intravenous analgesia.

Patients in the propofol group will receive further intravenous propofol until a bispectral index (BIS) value of 50 is reached.

The intravenous drip of propofol will be stopped after induction in the sevoflurane group and patients will receive sevoflurane as inhalation anaesthetic (1 MAC) until a BIS-value of 50. The surgeon will be blinded for patient allocation.

The surgical conditions will be graded postoperatively by the surgeon who performed the operation using the validated Boezaart grading scale. The endoscopic images will be evaluated in addition by 3 blinded surgeons using this same scale.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Double (Participant, Care Provider)

盲法说明

The surgeon and participant are blinded for randomization. The anesthesiologist is unblinded.

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patient planned for FESS surgery

排除标准

  • patients which receive anticoagulants
  • patients which have coagulation disorders
  • patients with high bleeding risk
  • patients with arterial hypertension
  • other decided by surgeon

研究组 & 干预措施

sevoflurane

Active Comparator

干预措施: Sevoflurane (Drug)

propofol

Active Comparator

干预措施: Propofol (Drug)

结局指标

主要结局

Boezaart surgical grading scale

时间窗: during surgery

Evaluation of surgical conditions by determination of the validated Boezaart surgical grading scale. Score 0 (no bleeding) to 5 (severe bleeding) The scale will be determined by the operating surgeon and 3 independent surgeons based on an endoscopic video recording.

次要结局

  • Surgery duration(Immediately after surgery)
  • Postoperative pain scores(in the first 48 hours after surgery)
  • Arterial blood pressure(During surgery)
  • Length of stay on the PACU(From arrival on the PACU until achievement of the PACU discharge criteria)
  • PONV scores(In the first 48 hours after surgery)

研究者

发起方
Algemeen Ziekenhuis Maria Middelares
申办方类型
Other
责任方
Principal Investigator
主要研究者

Dr. Alain Kalmar, MD, PhD

Staff Anesthesist

Algemeen Ziekenhuis Maria Middelares

研究点 (1)

Loading locations...

相似试验